Moreover, cycloastragenol can inhibit Akt/RPS6KB1 signaling pathway, promote cardiomyocyte autophagy and then alleviate isoproterenol-induced HF in rats, suggesting that cycloastragenol may be one of the promising candidates for the treatment of congestive HF. The gene discussed is AKT1; the disease is hydrops fetalis.